Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Saxagliptin (Onglyza) and linagliptin (Tradjenta) are both medications used to treat Type 2 diabetes, but they have some differences. Saxagliptin is available in a generic form, while linagliptin is only available as a brand-name medication. Both medications belong to the same drug class, dipeptidyl peptidase-4 (DPP-4) inhibitors, and are taken once daily by mouth, with or without food. However, saxagliptin has been associated with a higher risk of heart failure in certain people, whereas this risk is less clear for linagliptin. Common side effects of saxagliptin include upper respiratory infections and headaches, while linagliptin more commonly causes runny nose, sneezing, and diarrhea. Both medications can cause severe joint pain and have a risk of causing pancreatitis. You should talk to your healthcare provider to determine which medication is best for you based on your medical history and other medications you may be taking.
Saxagliptin (Onglyza)
Tradjenta (linagliptin)
Saxagliptin (Onglyza)
Tradjenta (linagliptin)
Summary of Onglyza vs. Tradjenta
Summary for DPP-4 inhibitor
Prescription only
Saxagliptin (Onglyza) is an add-on medication to exercise and a balanced, nutritious diet to improve blood sugar control in adults with Type 2 diabetes. It belongs to the drug class called dipeptidyl peptidase-4 (DPP-4) inhibitors. The saxagliptin (Onglyza) dosage is taken by mouth once daily. Possible side effects include certain infections and headaches. The brand name, Onglyza, is no longer available. But the lower-cost generic version is still available.
Summary for DDP-4 inhibitor
Prescription only
Tradjenta (linagliptin) is a prescription medication that's used along with a balanced diet and exercise to manage blood sugar levels in adults with Type 2 diabetes. It's a type of diabetes medication called a dipeptidyl peptidase-4 (DPP-4) inhibitor. The dose is 5 mg (1 tablet) that's taken by mouth once per day. Tradjenta (linagliptin) doesn't cause many side effects but can sometimes include runny nose, sneezing, and diarrhea. As of 2024, Tradjenta (linagliptin) is available as a brand-name medication only; there's no generic version yet.